Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics

This publication has 24 references indexed in Scilit:

• Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
  American Journal of Human Genetics, 1998
• Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
  The Lancet, 1997
• The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi Jews
  New England Journal of Medicine, 1997
• Early detection of familial ovarian cancer
  European Journal Of Cancer, 1996
• Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
  Published by Elsevier ,1996
• Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation
  Nature Genetics, 1995
• Identification of the breast cancer susceptibility gene BRCA2
  Nature, 1995
• Clinical heterogeneity of hereditary breast cancer and its impact on screening protocols: The dutch experience on 24 families under surveillance
  European Journal Of Cancer, 1993
• Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
  BMJ, 1993
• Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
  Science, 1990